Dr. Shravanti Bhowmik, Head of Operations at Sun Pharma Advanced Research Company, has resigned effective March 31, 2026, to take a new role within the group.
The company has complied with SEBI LODR Regulation 30 by informing the stock exchanges and attaching the resignation letter.
The resignation is for an internal transition, indicating a planned and amicable departure within the corporate group.